After many years in the oncology industry, and too many years as a caregiver, I’ve witnessed the dramatic changes in breast cancer treatments. Targeted therapies, antibody-drug conjugates, endocrine therapies, CDK4/6 inhibitors and immunotherapies have given many patients more options—and, in some cases, substantially more time. But […]
Artificial intelligence (AI) has been a huge topic of interest in the last several years in every aspect of life. In the pharmaceutical industry, Agentic AI refers to the use of artificial intelligence, machine learning, and automation to streamline, optimize, and speed up business and R&D […]
In the fall of 2025, the FDA quietly issued a huge number of compliance letters to the drug industry. This incredible level of enforcement went under the radar, shocking the space with more than 1000 warnings and over 100 letters of violation for noncompliance in relation […]
A small group of 60 doctors met in Philadelphia back in 1965. Today, that modest beginning has grown into the world’s largest ASCO congress, drawing more than 40,000 people to its massive 2.6 million square feet of exhibit space. I have personally attended 25 out of […]
Despite the controversy surrounding his views, Robert F. Kennedy Jr.’s impact on the pharmaceutical industry cannot be overstated. His advocacy has contributed to a more critical public dialogue about the pharmaceutical sector, sparking calls for greater transparency, better oversight, and a more ethical approach to drug […]
Our 2025 predictions indicate that the upcoming JPM Healthcare Conference could trigger the most significant wave of biotech acquisitions we’ve seen in years. The anticipation building around this event certainly reflects the transformative period ahead in healthcare investments. We’re particularly excited about the potential Biotech Deals […]
Nidhi Subbaraman at the Wall Street Journal provides an excellent overview of the brewing scientific publication crisis. The article (Flood of Fake Science Forces Multiple Journal Closures — Wiley to shutter 19 more journals, some tainted by fraud, WSJ, May 14, 2024), spurred by the recent […]
As the leader or CEO of a life science start-up or mid-stage, your company reputation and your proprietary technology are your main priorities. It is an extremely complex leadership role with many challenges: Is it time to engage a public relations firm? For CEO’s leading start-up […]
The theme of the 2023 American Society of Clinical Oncology was: “Partnering with Patients: The Cornerstone of Cancer Care and Research.” Selected by 2022-2023 ASCO President Eric P. Winer, MD, FASCO – he challenges the global oncology community to look at how interactions between clinicians and […]
Do you get daily or weekly media monitoring reports? If you are lucky enough to receive these kinds of intel reports are you leveraging them for maximum benefit? Since most of us are wearing multiple hats these days and running from one Zoom meeting to another, […]